Statistics
Publications
1
Citations
25
H-Index
1
Active since
2024
Affiliations
Novo Nordisk (United States)(Current)
Min Ju Kim is an author at Novo Nordisk (United States) specializing in immune checkpoint inhibitors, immune checkpoint inhibitor therapy, and pd-l1 blockade.
Publications per year
2024–2024
1
1